Skip to content
Loading Events

« All Events

2024 BioNJ C-Suite Summit

October 10 @ 7:30 am 4:30 pm

Against a backdrop of change, the biopharmaceutical industry – and the next wave of innovation – are at an inflection point. Join us to reflect on the state of innovation in life sciences and how companies can best navigate through this period of continued change.

TimeMARKET ACCESS
10:30 a.m. – 11:15 a.m.

Panel: Market Access & Reimbursement
The market access landscape is intricate and constantly evolving, with payers persistently refining their business models and strategies. This panel will explore the essential groundwork for securing optimal reimbursement and payer coverage, which are crucial for ensuring Patient access to treatments and, ultimately, improving Patient care. The panel will also address key issues manufacturers face including changing legislation, consolidation, M&A, gross to net and commercial launch planning.

  • Paul Hunter, Vice President, Market Access and Commercial Operations, Halozyme
  • Christopher Jackson, J.D., Managing Member, The Law Office of Christopher S. Jackson
  • Jake McDowell, Vice President, Head of Market Access, Pricing and Value at Partner Therapeutics
  • Conversation Leader: Tom Evegan, Principal, Strategy & Management Consulting; National Consulting Leader Life Sciences, RSM

Join us on October 10 for this important conversation. Registration is $695 for BioNJ Members and $895 for Future Members. (BioNJ is pleased to have maintained our pricing unchanged for the past three years.) Click here to register.

© 2024 BioNJ, All Rights Reserved